ERJ Open Research (Sep 2020)

Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol

  • Alexander G. Mathioudakis,
  • Fekri Abroug,
  • Alvar Agusti,
  • Per Bakke,
  • Konstantinos Bartziokas,
  • Bianca Beghe,
  • Andras Bikov,
  • Thomas Bradbury,
  • Guy Brusselle,
  • Cordula Cadus,
  • Courtney Coleman,
  • Marco Contoli,
  • Alexandru Corlateanu,
  • Olga Corlateanu,
  • Gerard Criner,
  • Balazs Csoma,
  • Alexander Emelyanov,
  • Rosa Faner,
  • Gustavo Fernandez Romero,
  • Zeineb Hammouda,
  • Peter Horváth,
  • Arturo Garcia Huerta,
  • Michael Jacobs,
  • Christine Jenkins,
  • Guy Joos,
  • Olga Kharevich,
  • Konstantinos Kostikas,
  • Elena Lapteva,
  • Zsofia Lazar,
  • Joerg D. Leuppi,
  • Carol Liddle,
  • Alejandra López-Giraldo,
  • Vanessa M. McDonald,
  • Rune Nielsen,
  • Alberto Papi,
  • Isabel Saraiva,
  • Galina Sergeeva,
  • Agni Sioutkou,
  • Pradeesh Sivapalan,
  • Elizabeth Stovold,
  • Hao Wang,
  • Fuqiang Wen,
  • Janelle Yorke,
  • Paula R. Williamson,
  • Jørgen Vestbo,
  • Jens-Ulrik Jensen

DOI
https://doi.org/10.1183/23120541.00193-2020
Journal volume & issue
Vol. 6, no. 3

Abstract

Read online

Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A core outcome set (COS) is a consensus-based minimum set of clinically important outcomes that should be evaluated in all RCTs in specific areas of health care. We present the study protocol of the COS-AECOPD ERS Task Force, aiming to develop a COS for COPD exacerbation management, that could remedy these limitations. For the development of this COS we follow standard methodology recommended by the COMET initiative. A comprehensive list of outcomes is assembled through a methodological systematic review of the outcomes reported in relevant RCTs. Qualitative research with patients with COPD will also be conducted, aiming to identify additional outcomes that may be important to patients, but are not currently addressed in clinical research studies. Prioritisation of the core outcomes will be facilitated through an extensive, multi-stakeholder Delphi survey with a global reach. Selection will be finalised in an international, multi-stakeholder meeting. For every core outcome, we will recommend a specific measurement instrument and standardised time points for evaluation. Selection of instruments will be based on evidence-informed consensus. Our work will improve the quality, usability and comparability of future RCTs on the management of COPD exacerbations and, ultimately, the care of patients with COPD. Multi-stakeholder engagement and societal support by the European Respiratory Society will raise awareness and promote implementation of the COS.